The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized controlled trial comparing conversion surgery with palliative chemotherapy in patients with initially unresectable cStage IVB/pStage IV advanced gastric cancer who presented remarkable response to chemotherapy: JCOG2301 (Conversion study).
 
Itaru Yasufuku
No Relationships to Disclose
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Naoki Takahashi
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kota Kawabata
No Relationships to Disclose
 
Masayuki Yokoyama
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Astellas Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; MC Medical; Medtronic; MSD; Nippon Kayaku; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takaki Yoshikawa
Honoraria - Astellas Pharma; AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson/Janssen; Medtronic; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly